Patents by Inventor Jay Chaplin

Jay Chaplin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Temperature based plasmid regulation system
    Patent number: 11466278
    Abstract: The present invention relates to a recombinant E. coli cell harbouring a recombinant plasmid wherein said E. coli cell has a thermo sensitive regulation of an essential E. coli gene.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: October 11, 2022
    Assignee: Novo Nordisk A/S
    Inventor: Jay Chaplin
  • Tolerogenic DNA vaccine
    Patent number: 11279745
    Abstract: The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: March 22, 2022
    Assignee: Novo Nordisk A/S
    Inventors: Jay Chaplin, Michael Wijaranakula
  • SAFE IMMUNO-STEALTH CELLS
    Publication number: 20210024884
    Abstract: The present invention relates to safe and immuno-stealth implantable cells and their use to prevent, treat or cure a disease.
    Type: Application
    Filed: October 14, 2020
    Publication date: January 28, 2021
    Inventors: Jay Chaplin, Ulrik Doehn
  • Tolerogenic DNA Vaccine
    Publication number: 20200339650
    Abstract: The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
    Type: Application
    Filed: April 26, 2019
    Publication date: October 29, 2020
    Inventors: Jay Chaplin, Michael Wijaranakula
  • TEMPERATURE BASED PLASMID REGULATION SYSTEM
    Publication number: 20190241898
    Abstract: The present invention relates to a recombinant E. coli cell harbouring a recombinant plasmid wherein said E. coli cell has a thermo sensitive regulation of an essential E. coli gene.
    Type: Application
    Filed: November 1, 2017
    Publication date: August 8, 2019
    Inventor: Jay Chaplin
  • Tolerogenic DNA Vaccine
    Publication number: 20180117133
    Abstract: The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
    Type: Application
    Filed: November 1, 2017
    Publication date: May 3, 2018
    Inventors: Jay Chaplin, Michael Wijaranakula
  • Molecules that bind CD180, compositions and methods of use
    Patent number: 9416188
    Abstract: Disclosed herein are novel CD180 binding molecules, methods for their identification, and methods for their use.
    Type: Grant
    Filed: January 12, 2016
    Date of Patent: August 16, 2016
    Assignee: University of Washington Through Its Center For Commercialization
    Inventors: Jay Chaplin, Martha Hayden-Ledbetter, Jeffrey Ledbetter, Edward A. Clark
  • MOLECULES THAT BIND CD180, COMPOSITIONS AND METHODS OF USE
    Publication number: 20160168257
    Abstract: Disclosed herein are novel CD180 binding molecules, methods for their identification, and methods for their use.
    Type: Application
    Filed: January 12, 2016
    Publication date: June 16, 2016
    Inventors: Jay Chaplin, Martha Hayden-Ledbetter, Jeffrey Ledbetter, Edward A. Clark
  • Molecules that bind CD180, compositions and methods of use
    Publication number: 20120020965
    Abstract: The present invention provides novel CD180 binding molecules, methods for their identification, and methods for their use.
    Type: Application
    Filed: February 24, 2011
    Publication date: January 26, 2012
    Applicants: higher education
    Inventors: Jay Chaplin, Martha Hayden-Ledbetter, Jeffrey Ledbetter, Ed Clark